Pharmacogenomic Study to Predict Neurotoxicity of Oxaliplatin

Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors

NCT00660426 ·Status: COMPLETED ·Phase: PHASE1

Gemox as First and Second Line Therapy in Unknown Primary Cancer

NCT00353145 ·Status: COMPLETED ·Phase: PHASE2

Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy

NCT02569723 ·Status: COMPLETED ·Phase: NA

Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer

NCT04034355 ·Status: TERMINATED ·Phase: PHASE3

Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site

NCT00193609 ·Status: COMPLETED ·Phase: PHASE2

Clinical Feasibility of Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Locally Advanced Cholangiocarcinoma

NCT05677217 ·Status: RECRUITING

Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan

NCT00496704 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

NCT00350961 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer

NCT02428101 ·Status: ENROLLING_BY_INVITATION

Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer

NCT00536809 ·Status: COMPLETED ·Phase: PHASE1

Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

NCT00453115 ·Status: UNKNOWN ·Phase: PHASE2

Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer

NCT00527930 ·Status: COMPLETED ·Phase: PHASE2

Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients

NCT01611727 ·Status: COMPLETED ·Phase: PHASE2

Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors

NCT07046650 ·Status: RECRUITING ·Phase: PHASE2

Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

NCT00436800 ·Status: COMPLETED ·Phase: PHASE2

Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

NCT01470443 ·Status: UNKNOWN ·Phase: PHASE3

Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients

NCT04425564 ·Status: COMPLETED ·Phase: PHASE2

Effects of Oxaliplatin-Induced Peripheral Neuropathy on Hand Function, Grip Strength and Quality of Life in Colorectal Cancer Patients

NCT07203066 ·Status: NOT_YET_RECRUITING

Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients

NCT02415829 ·Status: UNKNOWN ·Phase: PHASE2

Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract

NCT00127595 ·Status: TERMINATED ·Phase: PHASE2

Investigation of Cisplatin-Related Kidney Toxicity

NCT00984035 ·Status: COMPLETED

Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin

NCT00611962 ·Status: COMPLETED ·Phase: PHASE2

Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

NCT06649474 ·Status: RECRUITING ·Phase: NA

Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

NCT06282445 ·Status: RECRUITING ·Phase: PHASE2

Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin

NCT00831571 ·Status: COMPLETED